A detailed history of Artisan Partners Limited Partnership transactions in Exact Sciences Corp stock. As of the latest transaction made, Artisan Partners Limited Partnership holds 3,805,389 shares of EXAS stock, worth $265 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
3,805,389
Previous 3,111,931 22.28%
Holding current value
$265 Million
Previous $215 Million 25.19%
% of portfolio
0.25%
Previous 0.33%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$41.33 - $74.26 $28.7 Million - $51.5 Million
693,458 Added 22.28%
3,805,389 $161 Million
Q1 2024

May 13, 2024

SELL
$56.27 - $73.77 $76.4 Million - $100 Million
-1,358,347 Reduced 30.39%
3,111,931 $215 Million
Q4 2023

Feb 12, 2024

BUY
$59.06 - $75.72 $30 Million - $38.5 Million
508,764 Added 12.84%
4,470,278 $331 Million
Q3 2023

Nov 09, 2023

BUY
$65.94 - $99.04 $27.6 Million - $41.5 Million
418,770 Added 11.82%
3,961,514 $270 Million
Q2 2023

Aug 10, 2023

BUY
$62.68 - $95.05 $53.6 Million - $81.3 Million
855,418 Added 31.83%
3,542,744 $333 Million
Q1 2023

May 11, 2023

BUY
$47.19 - $70.77 $24.4 Million - $36.5 Million
516,233 Added 23.78%
2,687,326 $182 Million
Q4 2022

Feb 10, 2023

BUY
$30.35 - $53.15 $33.6 Million - $58.9 Million
1,107,474 Added 104.12%
2,171,093 $107 Million
Q3 2022

Nov 10, 2022

BUY
$31.97 - $49.37 $130,661 - $201,775
4,087 Added 0.39%
1,063,619 $34.6 Million
Q2 2022

Aug 12, 2022

SELL
$35.61 - $76.23 $571,682 - $1.22 Million
-16,054 Reduced 1.49%
1,059,532 $41.7 Million
Q1 2022

May 13, 2022

BUY
$57.56 - $82.54 $708,851 - $1.02 Million
12,315 Added 1.16%
1,075,586 $75.2 Million
Q4 2021

Feb 11, 2022

SELL
$72.5 - $100.68 $44 Million - $61.2 Million
-607,432 Reduced 36.36%
1,063,271 $82.8 Million
Q3 2021

Nov 12, 2021

SELL
$90.24 - $124.05 $79.9 Million - $110 Million
-885,258 Reduced 34.64%
1,670,703 $159 Million
Q2 2021

Aug 12, 2021

SELL
$93.66 - $139.27 $13.6 Million - $20.3 Million
-145,708 Reduced 5.39%
2,555,961 $318 Million
Q1 2021

May 11, 2021

SELL
$116.57 - $155.01 $57.6 Million - $76.6 Million
-494,188 Reduced 15.46%
2,701,669 $356 Million
Q4 2020

Feb 10, 2021

BUY
$99.61 - $142.12 $21.5 Million - $30.6 Million
215,604 Added 7.23%
3,195,857 $423 Million
Q3 2020

Nov 12, 2020

BUY
$72.92 - $102.01 $30.5 Million - $42.6 Million
417,778 Added 16.3%
2,980,253 $304 Million
Q2 2020

Aug 12, 2020

BUY
$55.75 - $92.75 $12.3 Million - $20.4 Million
219,919 Added 9.39%
2,562,475 $223 Million
Q1 2020

May 12, 2020

BUY
$37.9 - $104.44 $5.72 Million - $15.8 Million
150,842 Added 6.88%
2,342,556 $136 Million
Q4 2019

Feb 12, 2020

BUY
$77.66 - $99.74 $29.2 Million - $37.5 Million
375,796 Added 20.69%
2,191,714 $203 Million
Q3 2019

Nov 12, 2019

BUY
$90.37 - $122.49 $4.33 Million - $5.87 Million
47,952 Added 2.71%
1,815,918 $164 Million
Q2 2019

Aug 09, 2019

SELL
$89.51 - $118.04 $3.86 Million - $5.09 Million
-43,162 Reduced 2.38%
1,767,966 $209 Million
Q1 2019

May 10, 2019

SELL
$61.98 - $96.5 $3.18 Million - $4.96 Million
-51,375 Reduced 2.76%
1,811,128 $157 Million
Q4 2018

Feb 12, 2019

SELL
$56.04 - $82.66 $12.1 Million - $17.9 Million
-216,406 Reduced 10.41%
1,862,503 $118 Million
Q3 2018

Nov 13, 2018

BUY
$48.29 - $80.6 $9.63 Million - $16.1 Million
199,384 Added 10.61%
2,078,909 $164 Million
Q2 2018

Aug 10, 2018

BUY
$37.84 - $69.96 $14.6 Million - $27 Million
385,766 Added 25.83%
1,879,525 $112 Million
Q1 2018

May 10, 2018

BUY
$39.82 - $57.53 $59.5 Million - $85.9 Million
1,493,759 New
1,493,759 $60.2 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Artisan Partners Limited Partnership Portfolio

Follow Artisan Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.